It was nice seeing y'all again! Thank you for stimulating my neurones. See you next time! #COGNO Mustafa Khasraw

Another great session by Thoracic Oncology Group of Australasia with an amazing panel Malinda Itchins A/Prof Tim Clay A/Prof Tom John Zarnie Lwin discussing lorlatinib as first-line agent in ALK mNSCLC #Pfizerforthewin

Is chemotherapy synergistic to immunotherapy with PD(L)1 inhibition - or antagonistic? In vivo models Clinical Cancer Research suggest chemotherapy impacts transition of stem-like CD8 T cells to effector T cells and timing of administration could be better optimized. aacrjournals.org/clincancerres/…

It was my pleasure to co-hosting a podcast with Prof ONCODOC interviewing the amazing and knowledgeable Prof Lillian Siu discussing early phase trials! open.spotify.com/episode/7kGgiS…

We will be in Singapore in just 10 days time, for ASIA Bio on 24 and 25 April (and beyond!) - come and find us and say hello, or get in touch with us here: scientiaclinicalresearch.com.au/about-us/ Scientia Clinical Research (Sydney, Australia) #ASIABIO

Apply for the CRIS Cancer-Princess Margaret drug development fellowship CRIS contra el cáncer Princess Margaret Cancer Centre - great opportunity for those with interests in phase I trials and translational research criscancer.org/es/cris-prince…

Very nice thread about T cell tolerance and exhaustion!

My dear friend Sofia Mason eating a moon cake at #ACORD2024 given by ChenLee like a biscuit!

Amazing support from #AACR and #ASCO at the ACORD 2024 Protocol Writing! Thank you ACORD for bringing together such a stellar lineup of faculty! For a budding trialist like myself, it was an opportunity unlike any other! #inspirational 💥Tan Ya Hwee Mithat Gönen Professor Adrian Esterman

Going to #ACORD24 was a drag for me. But Jia (Jenny) Liu ravs about it, & I'm in the habit of following her footsteps! Dare I say, it is the BEST workshop I have ever attended. The highlight is definitely meeting Professor Adrian Esterman what an inspiration! Thank you organisers! PDG8-4-LYF!

Meeting the Singaporean doctors was definitely another highlight at #ACORD24. Made me feel I was back "home" again, even though I ran away from my "national duties". I'm pretty sure my English was turning into Singlish again by the end. Yu Yang Soon

Novel mRNA based strategy utilising a different part of the immune system. MANY unexplored immunotherapeutic targets: Ag-processing, cross-presentation&priming, induction of immunoproteosomes, immunodominance, epitope reportoire & MHC variation AND MANY MORE. Don't stop at ICIs.

Having done bench research & now mentored by experienced FIH trialists Charlotte Lemech & Christina Teng Scientia Clinical Research (Sydney, Australia), #ACORD is the missing link for my bench-2-bedside dream. Thank you Thoracic Oncology Group of Australasia & Megan Sanders for funding this awesome workshop. I'll bring this back to TOGA!

Oh wow, my PhD supervisor's PhD supervisor, Jonathan Yewdell, talking about methionine and oxidative stress... In Chinese, he would be my 師爺! He's still active but my supervisor is long retired 🤯😱

Congrats to ⁦Joe Y Chang⁩ and team for the development of an AI-based model to better select patients most likely to benefit from #SABR +/-#immunotherapy for lung cancer. #ASTRO24 #endcancer ⁦MD Anderson Cancer Center⁩

"Sensing DNA as danger: The discovery of cGAS" by Richard Flavell and Esen Sefik discusses the importance of #LaskerAward winner Zhijian "James" Chen's work. UT Southwestern Medical Center Immunity cell.com/immunity/fullt…

Amazing work. The more we understand the immune system, the better we can utilise it. The immune system is not only T cells. We need to learn to orchestrate the immune system better. NK cells, antigen presenting cells, B cells, chemokines, cytokines... We can, and will do better!

At Scientia Clinical Research (Sydney, Australia) we are running a trial using bispecific ADC targetting these 2 immune checkpoints expressed on tumour cells too! Excited about its outcomes! Christina Teng Charlotte Lemech

Had a vivid dream about #abscopal effect... Can my dream come true?

We're excited to announce that COGNO is now on LinkedIn! Stay updated on our latest developments in clinical trials and connect with our team. Follow us here: bit.ly/3BoXRt1 #ClinicalTrials #LinkedIn COSA